STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,621,000 | -68.7% | 794,675 | -54.5% | 0.02% | -65.4% |
Q2 2021 | $5,182,000 | +7.6% | 1,744,669 | 0.0% | 0.05% | +15.6% |
Q1 2021 | $4,815,000 | -43.2% | 1,744,669 | -50.0% | 0.04% | -39.2% |
Q4 2020 | $8,479,000 | +15.7% | 3,489,369 | 0.0% | 0.07% | -19.6% |
Q3 2020 | $7,328,000 | – | 3,489,369 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 6,612,065 | $13,819,000 | 13.33% |
Prosight Management, LP | 1,258,224 | $2,630,000 | 1.16% |
Stonepine Capital Management, LLC | 431,853 | $903,000 | 0.63% |
NEA Management Company, LLC | 4,141,308 | $8,665,000 | 0.41% |
Alambic Investment Management, L.P. | 118,364 | $247,000 | 0.21% |
683 Capital Management, LLC | 608,971 | $1,273,000 | 0.15% |
PA Capital LLC | 77,799 | $163,000 | 0.14% |
Hudson Bay Capital Management LP | 2,075,000 | $4,337,000 | 0.10% |
KNOTT DAVID M | 100,000 | $209,000 | 0.08% |
Aristides Capital LLC | 35,517 | $74,000 | 0.06% |